Recruitment of Cbl-b to B Cell Antigen Receptor Couples Antigen Recognition to Toll-like Receptor 9 Activation in Late Endosomes
Overview
Authors
Affiliations
Casitas B-lineage lymphoma-b (Cbl-b) is a ubiquitin ligase (E3) that modulates signaling by tagging molecules for degradation. It is a complex protein with multiple domains and binding partners that are not involved in ubiquitinating substrates. Herein, we demonstrate that Cbl-b, but not c-Cbl, is recruited to the clustered B cell antigen receptor (BCR) and that Cbl-b is required for entry of endocytosed BCRs into late endosomes. The E3 activity of Cbl-b is not necessary for BCR endocytic trafficking. Rather, the ubiquitin associated (UBA) domain is required. Furthermore, the Cbl-b UBA domain is sufficient to confer the receptor trafficking functions of Cbl-b on c-Cbl. Cbl-b is also required for entry of the Toll-like receptor 9 (TLR9) into late endosomes and for the in vitro activation of TLR9 by BCR-captured ligands. These data indicate that Cbl-b acts as a scaffolding molecule to coordinate the delivery of the BCR and TLR9 into subcellular compartments required for productively delivering BCR-captured ligands to TLR9.
Malinova D, Wasim L, Newman R, Martinez-Riano A, Engels N, Tolar P EMBO Rep. 2021; 22(9):e51328.
PMID: 34323351 PMC: 8419706. DOI: 10.15252/embr.202051328.
Sekiguchi N, Nomoto J, Nagata A, Kiyota M, Fukuda I, Yamada K Biomed Res Int. 2018; 2018:6728128.
PMID: 30402490 PMC: 6193339. DOI: 10.1155/2018/6728128.
Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB.
Bruening J, Lasswitz L, Banse P, Kahl S, Marinach C, Vondran F PLoS Pathog. 2018; 14(7):e1007111.
PMID: 30024968 PMC: 6053247. DOI: 10.1371/journal.ppat.1007111.
The immunobiology of ubiquitin-dependent B cell receptor functions.
Drake J Mol Immunol. 2018; 101:146-154.
PMID: 29940407 PMC: 6138560. DOI: 10.1016/j.molimm.2018.05.022.
Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity.
Taher T, Bystrom J, Ong V, Isenberg D, Renaudineau Y, Abraham D Clin Rev Allergy Immunol. 2017; 53(2):237-264.
PMID: 28456914 PMC: 5597704. DOI: 10.1007/s12016-017-8609-4.